YS Biopharma Co Ltd (YS)
0.9796
+0.03
(+3.10%)
USD |
NASDAQ |
May 20, 16:00
0.9796
0.00 (0.00%)
After-Hours: 16:18
YS Biopharma Debt to Equity Ratio: 0.9778 for Sept. 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2023 | 0.9778 |
June 30, 2023 | 0.7793 |
Date | Value |
---|---|
September 30, 2022 | -0.4709 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.4709
Minimum
Sep 2022
0.9778
Maximum
Sep 2023
0.4287
Average
0.7793
Median
Jun 2023
Debt to Equity Ratio Benchmarks
Sinovac Biotech Ltd | 0.0292 |
CASI Pharmaceuticals Inc | 0.7819 |
Zai Lab Ltd | 0.0633 |
Gracell Biotechnologies Inc (DELISTED) | -- |
Adagene Inc | 0.3109 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 220.84M |
Total Liabilities (Quarterly) | 144.48M |
Shareholders Equity (Quarterly) | 76.35M |
Current Ratio | 1.409 |
Net Debt Paydown Yield | -10.09% |